Sugar.fit, a healthtech startup that seeks to manage and reverse type 2 and pre-diabetes, said it has raised $11 million in a Series A funding round led by MassMutual Ventures, according to ETtech report.
Other participating investors include Cure.fit, Tanglin Venture Partners, and Endiya Partners. The fresh capital will be used to expand Sugar.fit’s product offering, launch an offline presence, and accelerate research and development in the field of diabetes management, as per a statement from the company.
“This investment will enable us to enhance our technology and expand our reach across India, ultimately helping more people take control of their diabetes and improve their health,” said Madan Somasundaram, co-founder and CEO of Sugar.fit.
Commenting on the investment, Anvesh Ramineni, managing partner at MassMutual Ventures, said, “We are thrilled to lead the Series A funding round for Sugar.fit. The team’s approach to diabetes management combines hardware, software and analytics to deliver a personalized program and drive lasting behavioral change for better health outcomes. We believe Sugar.fit will transform the health of millions, while battling the increasing incidence of diabetes in India.”
Founded in 2021, Sugar.fit raised $10 million in a seed funding round that same year. In the last 18 months, the startup has witnessed eightfold growth in paid subscribers, and currently serves more than 25,000 users on its platform, it said.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.